Pressure-Testing Decision-Maker Priorities Before a Regulated Market Entry

Start with the assumptions, not the research

Before commissioning any external work, get your leadership team to write down, individually, what they believe the top three priorities are for each key decision-maker group in the target market. Regulators. Major distributors. Institutional clients. Local competitors who could shape narrative. Political stakeholders where relevant.

The individual bit matters. If you run this as a group discussion first, you get consensus theatre. Written independently, you almost always find material disagreement across your own executive team about what stakeholders care about. That disagreement is your starting point. It tells you where your validation effort needs to focus.

What most teams get wrong: they treat assumptions as a single list. Good practice is to separate them into three tiers. What we believe and would bet the entry on. What we believe but haven't tested. What we're guessing. Only the first two are worth validating rigorously. The third tier needs different treatment: exploratory work, not confirmation.

Identify the assumptions that actually move the decision

Not every assumption matters equally. For each one, ask: if this turned out to be wrong, would we change the entry decision, the sequencing, the operating model, or the capital commitment? If the answer is no, park it. You are looking for the five to eight assumptions where being wrong reshapes the plan.

Typical high-consequence assumptions in a regulated market entry:

• What the regulator will treat as a credibility signal from a new entrant
• Whether incumbent distributors see you as a threat, an opportunity, or irrelevant
• What institutional clients actually value versus what they say in RFPs
• How local political stakeholders will read your entry narrative
• Where the real switching costs sit for target customers

Design validation that produces disconfirming evidence

The purpose is not to confirm your thesis. It is to find out where it breaks. Structure the work so that people with no stake in the entry decision are running it, and brief them explicitly to hunt for contradiction.

Use a mix of methods, sequenced deliberately:

Off-the-record conversations first. Commission a specialist firm or use trusted intermediaries to have candid discussions with former regulators, ex-distributor executives, and departed institutional buyers. People who have left roles speak more freely than those in them. Ten to fifteen well-chosen conversations will tell you more than fifty formal interviews.

Structured interviews second. Once you have a working hypothesis about where the gaps are, run formal interviews with current decision-makers, but through a third party who can guarantee anonymity. Anything attributable to your firm will produce curated answers.

Behavioural evidence third. Look at what these stakeholders have actually done in comparable situations. Regulatory decisions on recent new entrants. Distributor behaviour when other firms entered. Client procurement outcomes. Stated priorities and revealed priorities often differ.

Watch for the failure modes

Three things routinely go wrong:

The team validates the wrong assumptions. They test what is easy to test rather than what matters most. Force the exercise back to the high-consequence list.

The research confirms what leadership already believes. This is almost always a signal of poor design, not genuine alignment. If nothing surprised you, the questions were too leading or the sample was too narrow.

Findings get softened on the way up. Insist on hearing dissenting stakeholder views verbatim, not summarised. The nuance is where the risk sits.

Convert findings into a decision, not a report

The output should not be a 60-page deck. It should be a one-page assumption ledger: original assumption, evidence found, revised view, implication for the entry plan. For each material change, name what it means: delay, resequence, restructure the operating model, adjust the capital commitment, or walk away.

Good looks like this: the leadership team can point to at least two assumptions that were materially wrong, explain how the plan changed as a result, and describe one scenario in which they would still not proceed.

Your next move

Before your next steering committee, ask each executive sponsor to submit their top three assumed priorities for each stakeholder group, in writing, independently. Compare them. If there is significant divergence, or suspiciously tight alignment, you have your answer on whether validation work is needed. Commission it before the capital paper goes to the board, not after.